Paper33112539
Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study.
Shahidi S and 5 others. Asian Pac J Cancer Prev, 2020. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study. Papers, record 33112539. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33112539
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antioxidants | Major topic |
| Biomarkers, Tumor | Major topic |
| Fibronectins | Major topic |
| Malondialdehyde | Major topic |
| Oxidative Stress | Major topic |
| Stomach Neoplasms | Major topic |
| Aged | |
| Case-Control Studies | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Oxidation-Reduction | |
| Prognosis | |
| Superoxide Dismutase |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23618831 | Beyond oxidative stress: an immunologist's guide to reactive oxygen species. | Nat Rev Immunol | 2013 | https://conductscience.org/library/papers/23618831 | PubMed |
| 2 | 8660627 | The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. | Anal Biochem | 1996 | https://conductscience.org/library/papers/8660627 | PubMed |
| 3 | 803541 | The estimation of red cell superoxide dismutase activity. | J Lab Clin Med | 1975 | https://conductscience.org/library/papers/803541 | PubMed |
| 4 | 10644478 | MnSOD expression is increased in metastatic gastric cancer. | J Surg Res | 2000 | https://conductscience.org/library/papers/10644478 | PubMed |
| 5 | 27986567 | Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/27986567 | PubMed |
| 6 | 26963139 | Irisin immunohistochemistry in gastrointestinal system cancers. | Biotech Histochem | 2016 | https://conductscience.org/library/papers/26963139 | PubMed |
| 7 | 29098483 | Irisin Alleviates Advanced Glycation End Products-Induced Inflammation and Endothelial Dysfunction via Inhibiting ROS-NLRP3 Inflammasome Signaling. | Inflammation | 2018 | https://conductscience.org/library/papers/29098483 | PubMed |
| 8 | 27545213 | Irisin immunostaining characteristics of breast and ovarian cancer cells. | Cell Mol Biol (Noisy-le-grand) | 2016 | https://conductscience.org/library/papers/27545213 | PubMed |
| 9 | 22247598 | Roles of oxidative stress in stomach disorders. | J Clin Biochem Nutr | 2012 | https://conductscience.org/library/papers/22247598 | PubMed |
| 10 | 28012856 | Increased FNDC5/Irisin expression in human hepatocellular carcinoma. | Peptides | 2017 | https://conductscience.org/library/papers/28012856 | PubMed |
| 11 | 31114131 | Recent advances in gastric cancer early diagnosis. | World J Gastroenterol | 2019 | https://conductscience.org/library/papers/31114131 | PubMed |
| 12 | 27256459 | Investigation of the expression of irisin and some cachectic factors in mice with experimentally induced gastric cancer. | QJM | 2016 | https://conductscience.org/library/papers/27256459 | PubMed |
| 13 | 29445300 | Gastric cancer: epidemiology, prevention, classification, and treatment. | Cancer Manag Res | 2018 | https://conductscience.org/library/papers/29445300 | PubMed |
| 14 | 30018477 | Biomarkers of gastric cancer: Current topics and future perspective. | World J Gastroenterol | 2018 | https://conductscience.org/library/papers/30018477 | PubMed |
| 15 | 29522296 | The Diagnostic Value of FNDC5/Irisin in Renal Cell Cancer. | Int Braz J Urol | 2018 | https://conductscience.org/library/papers/29522296 | PubMed |
| 16 | 29770165 | Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies. | Oxid Med Cell Longev | 2018 | https://conductscience.org/library/papers/29770165 | PubMed |
| 17 | 21373264 | Ghrelin and oxidative stress in gastrointestinal tract. | J Clin Biochem Nutr | 2011 | https://conductscience.org/library/papers/21373264 | PubMed |
| 18 | 31114326 | Comparison of irisin hormone expression between thyroid cancer tissues and oncocytic variant cells. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31114326 | PubMed |
| 19 | 23436919 | Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. | J Clin Endocrinol Metab | 2013 | https://conductscience.org/library/papers/23436919 | PubMed |
| 20 | 26560078 | Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26560078 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42940170 | Circulating R-Spondin-1, Nesfatin-1, and Irisin in Gastric Cancer: A Biologically Complementary Multimarker Signature. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940170 | PubMed |
| 41002741 | Diagnostic and Therapeutic Value of the Exercise-Induced Myokine Irisin in Cancer Biology: A Comprehensive Review. | Diseases | 2025 | https://conductscience.org/library/papers/41002741 | PubMed |
| 40859977 | Irisin's Dual Role in Malignant Tumors and Its Potential as a Biomarker and Therapeutic Target. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40859977 | PubMed |
| 40851242 | Physical exercise and irisin: managing obesity and related comorbidities. | Rom J Morphol Embryol | 2025 | https://conductscience.org/library/papers/40851242 | PubMed |
| 40725790 | Irisin Concentrations in Children and Adolescent Cancer Survivors and Their Relation to Metabolic, Bone, and Reproductive Profile: A Pilot Case-Control Study. | J Clin Med | 2025 | https://conductscience.org/library/papers/40725790 | PubMed |
| 38671861 | The Role of the Myokine Irisin in the Protection and Carcinogenesis of the Gastrointestinal Tract. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38671861 | PubMed |
| 38275878 | Impact of Nutritional Status of Patients with Head and Neck Squamous Cell Carcinoma on the Expression Profile of Ghrelin, Irisin, and Titin. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38275878 | PubMed |
| 36077366 | Implication of Irisin in Different Types of Cancer: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077366 | PubMed |
| 36045563 | High Level of Irisin as a Marker of Malnutrition in Head and Neck Cancer Patients Subjected to Radiotherapy. | Med Sci Monit | 2022 | https://conductscience.org/library/papers/36045563 | PubMed |
| 36037118 | The Relationship between Circulating Irisin and Oxidative Stress in Gastric and Colorectal Cancer Patients. | Asian Pac J Cancer Prev | 2022 | https://conductscience.org/library/papers/36037118 | PubMed |
| 34981027 | Irisin and Carcinoembryonic Antigen (CEA) as Potential Diagnostic Biomarkers in Gastric and Colorectal Cancers. | Rep Biochem Mol Biol | 2021 | https://conductscience.org/library/papers/34981027 | PubMed |
| 34204674 | The Role of Irisin in Cancer Disease. | Cells | 2021 | https://conductscience.org/library/papers/34204674 | PubMed |
| 34071869 | Current Evidence of the Role of the Myokine Irisin in Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34071869 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33112539
GET https://conductscience.org/api/papers/v1/33112539/references?page=2